FindTrial
Sign In

to check the effect of bilirubin and albumin ratio with duration of phototherapy

A prospective study of association of bilirubin and albumin ratio on the immediate outcome of neonatal hyperbilirubinemia - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070378
Enrollment
55
Registered
2024-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P84- Other problems with newborn

Interventions

Intervention1: NIL: NA Control Intervention1: NIL: NA

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the Neonates admitted in NICU receiving phototherapy for hyperbilirubinemia after 24 hours of life.

Exclusion criteria

Exclusion criteria: Neonates with Conjugated Hyperbilirubinemia. Neonates with co-morbidities like acute renal failure, Hydrops foetalis, congenital nephritic syndrome, and other diseases that mimic BIND as well as death due to other reasons

Design outcomes

Primary

MeasureTime frame
duration of phototherapy significantly correlates to the bilirubin and albumin ratioTimepoint: 24 hours—

Secondary

MeasureTime frame
NILTimepoint: NA—

Countries

India

Contacts

Public ContactDr R J Meshram

Datta Meghe Institute of Medical sciences, Wardha

rjmeshram@yahoo.com98237639889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026